NO740532L - Analogifremgangsmåte for fremstilling av terapeutisk aktive sulfonylurinstoffderivater. - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive sulfonylurinstoffderivater.

Info

Publication number
NO740532L
NO740532L NO740532A NO740532A NO740532L NO 740532 L NO740532 L NO 740532L NO 740532 A NO740532 A NO 740532A NO 740532 A NO740532 A NO 740532A NO 740532 L NO740532 L NO 740532L
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
analogous process
sulfonylurea derivatives
active sulfonylurea
Prior art date
Application number
NO740532A
Other languages
English (en)
Other versions
NO140820B (no
NO140820C (no
Inventor
Donald Ernest Kuhla
Hans Eberhardt Wiedermann
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO740532L publication Critical patent/NO740532L/no
Publication of NO140820B publication Critical patent/NO140820B/no
Publication of NO140820C publication Critical patent/NO140820C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)
NO740532A 1973-03-07 1974-02-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater NO140820C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00338965A US3856806A (en) 1973-03-07 1973-03-07 Thiazolecarboxamide sulfonylurea hypoglycemic agents

Publications (3)

Publication Number Publication Date
NO740532L true NO740532L (no) 1974-09-10
NO140820B NO140820B (no) 1979-08-13
NO140820C NO140820C (no) 1979-11-21

Family

ID=23326893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740532A NO140820C (no) 1973-03-07 1974-02-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonylurinstoffderivater

Country Status (29)

Country Link
US (1) US3856806A (no)
JP (1) JPS5418258B2 (no)
AR (1) AR201135A1 (no)
AT (1) AT342614B (no)
AU (1) AU458655B2 (no)
BE (1) BE811866A (no)
BG (1) BG25376A3 (no)
CA (1) CA1015362A (no)
CH (1) CH581639A5 (no)
CS (1) CS176268B2 (no)
DD (1) DD110500A5 (no)
DE (1) DE2410003A1 (no)
DK (1) DK139579B (no)
EG (1) EG11270A (no)
ES (1) ES423865A1 (no)
FI (1) FI55034C (no)
FR (1) FR2220259B1 (no)
GB (1) GB1409518A (no)
HU (1) HU167511B (no)
IE (1) IE38955B1 (no)
IL (1) IL44230A (no)
LU (1) LU69565A1 (no)
NL (1) NL7402804A (no)
NO (1) NO140820C (no)
PL (1) PL96884B1 (no)
RO (1) RO69724A (no)
SE (1) SE393984B (no)
SU (1) SU617012A3 (no)
ZA (1) ZA741439B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714920D0 (en) * 1987-06-25 1987-07-29 Shell Int Research Thiazole derivatives

Also Published As

Publication number Publication date
DE2410003A1 (de) 1974-09-26
NL7402804A (no) 1974-09-10
DD110500A5 (no) 1974-12-20
AU458655B2 (en) 1975-03-06
US3856806A (en) 1974-12-24
AT342614B (de) 1978-04-10
JPS5029557A (no) 1975-03-25
GB1409518A (en) 1975-10-08
ZA741439B (en) 1975-02-26
FI55034C (fi) 1979-05-10
RO69724A (ro) 1981-04-30
CS176268B2 (no) 1977-06-30
CH581639A5 (no) 1976-11-15
EG11270A (en) 1977-08-15
JPS5418258B2 (no) 1979-07-06
ES423865A1 (es) 1976-03-16
AR201135A1 (es) 1975-02-14
FR2220259A1 (no) 1974-10-04
CA1015362A (en) 1977-08-09
BE811866A (fr) 1974-09-05
IE38955B1 (en) 1978-07-05
ATA174074A (de) 1977-08-15
SE393984B (sv) 1977-05-31
NO140820B (no) 1979-08-13
AU6586474A (en) 1975-03-06
NO140820C (no) 1979-11-21
PL96884B1 (pl) 1978-01-31
FR2220259B1 (no) 1977-10-28
DK139579C (no) 1979-08-27
IL44230A (en) 1976-12-31
LU69565A1 (no) 1974-10-09
IL44230A0 (en) 1974-05-16
FI55034B (fi) 1979-01-31
IE38955L (en) 1974-09-07
SU617012A3 (ru) 1978-07-25
BG25376A3 (en) 1978-09-15
HU167511B (no) 1975-10-28
DK139579B (da) 1979-03-12

Similar Documents

Publication Publication Date Title
NO741815L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive etylenderivater.
NO740516L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive indolderivater.
NO140301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner
NO740137L (no) Analogifremgangsmåte ved fremstilling av terapeutisk virksomme karboksylsyrederivater.
NO741227L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive penicillinderivater.
NO740272L (no) Analogifremgangsmåte til fremstilling av 3-substituerte 4-fenylpiperidiner.
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NO740349L (no) Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater.
NO741744L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin.
NO741486L (no) Fremgangsmåte for fremstilling av xylitol.
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO741607L (no) Fremgangsmåte for fremstilling av isocyanater.
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO741364L (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser.
FI49827C (fi) Menetelmä terapeuttisesti vaikuttavien substituoitujen 3-hydroksimetyy li-isokinoliinien valmistamiseksi.
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
NO740411L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on.